79 Results for "

antitumour activity

" in MedChemExpress (MCE) Product Catalog:
Products (79)

79 Results for "antitumour activity" in MCE Product Catalog:

217
217 Publications Verification
Cat. No.: HY-50895A
CAS No.: 184475-55-6
Synonyms: ZD-1839 hydrochloride
Target:  

EGFR

Research Areas:  

Cancer

Gefitinib hydrochloride (ZD1839 hydrochloride) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib hydrochloride selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib hydrochloride also induces autophagy. Gefitinib hydrochloride has antitumour activity .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-101488
CAS No.: 1010100-07-8
Purity:  99.85%
Research Areas:  

Cancer

CC-885 is a cereblon (CRBN) modulator with potent anti-tumour activity. CC-885 is also a known degrader of GSPT1, inhibiting protein translation.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-129389
CAS No.: 3554-93-6
Purity:  99.95%
Target:  

Glycosyltransferase

Research Areas:  

Cancer

Benzyl-α-GalNAc is a potent O-glycosylation inhibitor. Benzyl-α-GalNAc effectively inhibits the proliferation and activation of LX-2 cells and suppresses the expression of collagen I/III, which has good potential for investigation in liver fibrosis. Benzyl-α-GalNAc also significantly enhances the anti-tumour activity of 5-Fluorouracil (HY-90006) (e.g. pancreatic cancer) by inhibiting O-glycosylation .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-16293
CAS No.: 497871-47-3
Synonyms: PM01183; LY-01017
Research Areas:  

Cancer

Lurbinectedin (PM01183) is a DNA minor groove covalent binder with potent anti-tumour activity; inhibits RMG1 and RMG2 cell growth with IC50 values of 1.25 and 1.16 nM, respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-103160A
CAS No.: 58337-38-5
Purity:  99.67%
EHNA hydrochloride is a potent and selective dual inhibitor of cyclic nucleotide phosphodiesterase 2 (PDE2)(IC50=4 μM) and adenosine deaminase (ADA). EHNA hydrochloride exerts a concentration inhibition of the cGMP-stimulated PDE II (cGs-PDE)(IC50:0.8 μM (human), 2 μM (porcine myocardium)), but has smaller inhibitory effect on the unstimulated PDE2 activity. EHNA hydrochloride play roles in mediating diverse pharmacological responses, including antiviral, antitumour and antiarrhythmic effects .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-111651
CAS No.: 2101315-36-8
Purity:  98.23%
Gboxin is an oxidative phosphorylation (OXPHOS) inhibitor that targets glioblastoma. Gboxin inhibits the activity of F0F1 ATP synthase. Antitumour activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N1214
CAS No.: 111-02-4
Synonyms: Super Squalene; trans-Squalene; AddaVax
Squalene (Super Squalene) is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, antiatherosclerotic, cardioprotective, antioxidant, and antitumour activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-103396
CAS No.: 82952-64-5
Purity:  98.09%
Synonyms: CI-898 glucuronate
Target:  

Antifolate Bacterial

Research Areas:  

Infection Cancer

Trimetrexate glucuronate (NSC 352122) is a folic acid antagonist. Trimetrexate glucuronate affects DNA and RNA synthesis by inhibiting dihydrofolate reductase and preventing the synthesis of purine nucleotides and thymidylate. Trimetrexate glucuronate has potential antitumour activity and can also be used to inhibit Pneumocystis carinii pneumonia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19350
CAS No.: 537034-17-6
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

BML-210 is a potent HDAC inhibitor. BML-210 can inhibit the HDAC4-VP16-driven reporter signal with an apparent IC50 of ∼5 µM. BML-210 has a specific disruptive effect on the HDAC4:MEF2 interaction. BML-210 causes an increase in the G0/G1 phase. BML-210 induces apoptosis and displays antitumour activities in orthotopic mammary tumours in mice .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-147895
CAS No.: 56173-05-8
Purity:  ≥98.0%
Research Areas:  

Cancer

PCAF-IN-2 (compound 17) is a potent PCAF inhibitor with an IC50 value of 5.31 µM. PCAF-IN-2 shows anti-tumour activity. CAF-IN-2 induces apoptosis and arrest the cell cycle at the G2/M phase .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15228
CAS No.: 865838-26-2
Purity:  99.25%
Synonyms: TV-1360; Fluorocyclopentenylcytosine
Research Areas:  

Cancer

RX-3117 (TV-1360) is a potent and orally active anticancer and antimetaboliteagent. RX-3117 inhibits DNA methyltransferase 1 (DNMT1). RX-3117 shows antiproliferative and anti-tumour activity. RX-3117 induces cell cycle arrest at S phase and apoptosis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N2447
CAS No.: 21018-84-8
Amarogentin is a secoiridoid glycoside that is mainly extracted from Swertia and Gentiana roots. Amarogentin exhibits many biological effects, including anti-oxidative, anti-tumour, and anti-diabetic activities. Amarogentin exerts hepatoprotective and immunomodulatory effects. Amarogentin promotes apoptosis, arrests G2/M cell cycle and downregulates of PI3K/Akt/mTOR signalling pathways. Amarogentin exerts beneficial vasculo-metabolic effect by activating AMPK .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99380
CAS No.: 2169946-15-8
Synonyms: ZW 25; ZW-49 Antibody

Target:  

EGFR

Research Areas:  

Cancer

Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125098
CAS No.: 1149-99-1
Purity:  98.01%
Illudin S, a cytotoxic Illudin, is a natural sesquiterpene with strong anti-tumour and antiviral activities. Illudin S has genotoxic activities. Illudin S blocks the G1-S phase interface of the cell cycle in human leukemia cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3845
CAS No.: 2061-64-5
Ergosterol peroxide is a steroid derivative and can be isolated from a variety of fungi, yeast, lichens or sponges. Ergosterol peroxide has anti-tumour, proapoptotic, anti-inflammatory, anti-mycobacterial, and anti-proliferative activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113604
CAS No.: 10245-81-5
Purity:  99.63%
Pentabromopseudilin (PBrP) is a marine antibiotic isolated from the marine bacteria Pseudomonas bromoutilis and Alteromonas luteoviolaceus. PBrP exhibits antimicrobial, anti-tumour and phytotoxic activities. PBrP is a reversible and allosteric inhibitor of myosin Va (MyoVa). PBrP also is a potent inhibitor of transforming growth factor-β (TGF-β) activity. PBrP can be used for the research of fibrotic diseases and cancer .
loading...
    loading...
Cat. No.: HY-N1214S
CAS No.: 1875101-86-2
Synonyms: Super Squalene-d6; trans-Squalene-d6; AddaVax-d6
Squalene-d6 (Super Squalene-d6) is a deuterium labeled Squalene. Squalene (Super Squalene) is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, antiatherosclerotic, cardioprotective, antioxidant, and antitumour activity .
loading...
    loading...
Cat. No.: HY-121401A
CAS No.: 18486-69-6
Purity:  99.11%
Synonyms: (1R)-(−)-Myrtenal; (−)-(1R,5S)-Myrtenal
(-)-Myrtenal ((1R)-(-)-Myrtenal) is an orally active terpene with antitumour activity. (-)-Myrtenal ameliorates hyperglycemia by enhancing GLUT2 through Akt in the skeletal muscle and liver of diabetic rats .
loading...
    loading...
Cat. No.: HY-175606
CAS No.: 2588489-03-4
Target:  

ATP Citrate Lyase

Research Areas:  

Cancer

EVT0185 is an orally active ATP citrate lyase (ACLY) inhibitor. EVT0185 is converted to a CoA thioester in the liver by SLC27A2 and interacts with the CoA-binding site of ACLY. EVT0185-CoA inhibits ACLY activity with an IC50 of 2.5 μM. EVT0185 can phenocopy the immune and antitumour effects of genetic ACLY deletion. EVT0185 can increase tumour-infiltrating B cells and chemokine CXCL13 levels. EVT0185 can be used for the research of cancer, such as hepatocellular carcinoma (HCC) .
loading...
    loading...
Cat. No.: HY-P9964
CAS No.: 906805-06-9
Synonyms: 11F8; IMC-11F8; LY3012211

Target:  

EGFR

Research Areas:  

Cancer

Necitumumab (11F8; IMC-11F8; LY3012211) is a human IgG monoclonal antibody directed against EGFR. Necitumumab binds to the EGF binding site of EGFR, blocks ligand binding, neutralizes ligand-induced EGFR phosphorylation and downstream signaling, induces EGFR internalization and degradation, and mediates antibody-dependent cellular cytotoxicity (ADCC) in EGFR-expressing cells. Necitumumab enhances antitumour activity in combination with Gemcitabine (HY-17026) and Cisplatin (HY-17394) in murine non-small-cell lung cancer xenograft models. Necitumumab can be used in research on cancers such as non-small cell lung cancer and colorectal cancer .
loading...
    loading...